FIELD: chemistry.
SUBSTANCE: invention relates to rotigotine behenate represented by formula (I):
(I)
and crystalline forms thereof (I) and (II), wherein said crystalline forms have characteristic peaks expressed in degrees 2θ(±0.2 2θ), at 21.563, 21.156, 23.295, 21.955 and 20.838 on an X-ray powder diffraction pattern obtained with radiation of Cu-Kα for form (I) and at 3.274, 21.481, 23.887 for form (II).
EFFECT: said rotigotine behenate is characterized by the ability to maintain its effective concentration in plasma for a long period of time, has high bioavailability and can provide the effect of prolonged, effective and stable release.
19 cl, 10 dwg, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRIDILAMINE FUMARATE AND ITS CRYSTALS | 2015 |
|
RU2684278C1 |
| CRYSTAL FORM OF PHOSPHODIESTERASE INHIBITOR, METHOD OF ITS PREPARATION AND USE | 2020 |
|
RU2814498C2 |
| CRYSTALLINE FORM OF A TRICYCLIC COMPOUND AND APPLICATION THEREOF | 2019 |
|
RU2775753C1 |
| SALTS AND CRYSTALLINE FORMS OF DIAZABENZOFLUORANTHENE COMPOUNDS | 2017 |
|
RU2762189C2 |
| NOVEL SOLID FORMS (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | 2020 |
|
RU2820501C2 |
| CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | 2017 |
|
RU2719384C1 |
| POLYMORPH MALEATE OF DIPEPTIDYL PEPTIDASE INHIBITOR IV (DPPIV) AND A METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2732577C1 |
| CRYSTALLINE FORM OF INHIBITOR BISULPHATE JAK AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2704795C2 |
| SALT FORM OF ISOQUINOLINONE TYPE COMPOUND AS ROCK INHIBITOR AND METHOD FOR ITS PREPARATION | 2021 |
|
RU2821792C1 |
| NEW CRYSTALLINE SALT FORM OF 2,2-DIMETHYL-6-((4-((3,4,5-TRIMETHOXYPHENYL)AMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-2H-PYRIDO[3,2-B][1,4]OXAZIN-3(4H)-ONE FOR MEDICAL USE | 2016 |
|
RU2621187C1 |
